Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
Background: The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has been associated with a significant decline in coronavirus disease 2019 (COVID-19) hospitalizations and deaths. However, little is known about the benefits experienced by different population groups an...
Guardado en:
Autores principales: | Ignacio Barandalla, Carmen Alvarez, Pablo Barreiro, Carmen de Mendoza, Rubén González-Crespo, Vicente Soriano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2260ed96fe94073a6f58d39e72cc77c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021) -
Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021) -
Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013–2018
por: J. Ruiz-Contreras, et al.
Publicado: (2021) -
Sweet Syndrome Following SARS-CoV2 Vaccination
por: Maria Efenesia Baffa, et al.
Publicado: (2021) -
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines
por: Francesco Bellinato, et al.
Publicado: (2021)